RESUMO
As a multilevel and multidisciplinary field, neuroscience is designed to interact with various branches of natural and applied sciences as well as with humanities and philosophy. The continental tradition in philosophy, particularly over the past 20 years, tended to establish strong connections with biology and neuroscience findings. This cross fertilization can however be impeded by conceptual intricacies, such as those surrounding the concept of plasticity. The use of this concept has broadened as scientists applied it to explore an ever-growing range of biological phenomena. Here, we examine the consequences of this ambiguity in an interdisciplinary context through the analysis of the concept of "destructive plasticity" in the philosophical writings of Catherine Malabou. The term "destructive plasticity" was coined by Malabou in 2009 to refer to all processes leading to psycho-cognitive and emotional alterations following traumatic or nontraumatic brain injuries or resulting from neurodevelopmental disorders. By comparing it with the neuroscientific definitions of plasticity, we discuss the epistemological obstacles and possibilities related to the integration of this concept into neuroscience. Improving interdisciplinary exchanges requires an advanced and sophisticated manipulation of neurobiological concepts. These concepts are not only intended to guide research programmes within neuroscience but also to organize and frame the dialogue between different theoretical backgrounds.
RESUMO
Autism spectrum disorders (ASD) are complex neurodevelopmental disorders with a very large number of risk loci detected in the genome. However, at best, each of them explains rare cases, the majority being idiopathic. Genomic data on ASD derive mostly from post-mortem brain analyses or cell lines derived from blood or patient-specific induced pluripotent stem cells (iPSCS). Therefore, the transcriptional and regulatory architecture of the nervous system, particularly during early developmental periods, remains highly incomplete. To access the critical disturbances that may have occurred during pregnancy or early childhood, we recently isolated stem cells from the nasal cavity of anesthetized patients diagnosed for ASD and compared them to stem cells from gender-matched control individuals without neuropsychiatric disorders. This allowed us to discover MOCOS, a non-mutated molybdenum cofactor sulfurase-coding gene that was under-expressed in the stem cells of most ASD patients of our cohort, disturbing redox homeostasis and synaptogenesis. We now report that a divergent transcription upstream of MOCOS generates an antisense long noncoding RNA, to which we coined the name COSMOC. Surprisingly, COSMOC is strongly under-expressed in all ASD patients of our cohort with the exception of a patient affected by Asperger syndrome. Knockdown studies indicate that loss of COSMOC reduces MOCOS expression, destabilizes lipid and energy metabolisms of stem cells, but also affects neuronal maturation and splicing of synaptic genes. Impaired expression of the COSMOC/MOCOS bidirectional unit might shed new lights on the origins of ASD that could be of importance for future translational studies.
Assuntos
Síndrome de Asperger , Transtorno do Espectro Autista , Células-Tronco Pluripotentes Induzidas , Transtornos do Neurodesenvolvimento , Sulfurtransferases/genética , Transtorno do Espectro Autista/genética , Humanos , Sistema NervosoRESUMO
Animals strongly rely on chemical senses to uncover the outside world and adjust their behaviour. Chemical signals are perceived by facial sensitive chemosensors that can be clustered into three families, namely the gustatory (TASR), olfactory (OR, TAAR) and pheromonal (VNR, FPR) receptors. Over recent decades, chemoreceptors were identified in non-facial parts of the body, including the brain. In order to map chemoreceptors within the encephalon, we performed a study based on four brain atlases. The transcript expression of selected members of the three chemoreceptor families and their canonical partners was analysed in major areas of healthy and demented human brains. Genes encoding all studied chemoreceptors are transcribed in the central nervous system, particularly in the limbic system. RNA of their canonical transduction partners (G proteins, ion channels) are also observed in all studied brain areas, reinforcing the suggestion that cerebral chemoreceptors are functional. In addition, we noticed that: (i) bitterness-associated receptors display an enriched expression, (ii) the brain is equipped to sense trace amines and pheromonal cues and (iii) chemoreceptor RNA expression varies with age, but not dementia or brain trauma. Extensive studies are now required to further understand how the brain makes sense of endogenous chemicals.
Assuntos
Encéfalo/fisiologia , Células Quimiorreceptoras/metabolismo , Regulação da Expressão Gênica , Sistema Límbico/metabolismo , RNA Mensageiro/genética , Biomarcadores , Suscetibilidade a Doenças , Humanos , Vias NeuraisRESUMO
Over the recent years, several methods have been experienced to repair injured peripheral nerves. Among investigated strategies, the use of natural or synthetic conduits was validated for clinical application. In this study, we assessed the therapeutic potential of vein guides, transplanted immediately or two weeks after a peroneal nerve injury and filled with olfactory ecto-mesenchymal stem cells (OEMSC). Rats were randomly allocated to five groups. A3 mm peroneal nerve loss was bridged, acutely or chronically, with a 1 cm long femoral vein and with/without OEMSCs. These four groups were compared to unoperated rats (Control group). OEMSCs were purified from male olfactory mucosae and grafted into female hosts. Three months after surgery, nerve repair was analyzed by measuring locomotor function, mechanical muscle properties, muscle mass, axon number, and myelination. We observed that stem cells significantly (i) increased locomotor recovery, (ii) partially maintained the contractile phenotype of the target muscle, and (iii) augmented the number of growing axons. OEMSCs remained in the nerve and did not migrate in other organs. These results open the way for a phase I/IIa clinical trial based on the autologous engraftment of OEMSCs in patients with a nerve injury, especially those with neglected wounds.
Assuntos
Axônios/metabolismo , Locomoção , Transplante de Células-Tronco Mesenquimais , Regeneração Nervosa , Mucosa Olfatória/citologia , Mucosa Olfatória/transplante , Nervo Fibular/lesões , Nervo Fibular/metabolismo , Animais , Modelos Animais de Doenças , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Bainha de Mielina/metabolismo , Tamanho do Órgão , Traumatismos dos Nervos Periféricos/etiologia , Traumatismos dos Nervos Periféricos/metabolismo , Traumatismos dos Nervos Periféricos/patologia , Traumatismos dos Nervos Periféricos/terapia , Nervo Fibular/fisiopatologia , RatosRESUMO
BACKGROUND: Stem cell-based therapies are an attractive option to promote regeneration and repair defective tissues and organs. Thanks to their multipotency, high proliferation rate and the lack of major ethical limitations, "olfactory ecto-mesenchymal stem cells" (OE-MSCs) have been described as a promising candidate to treat a variety of damaged tissues. Easily accessible in the nasal cavity of most mammals, these cells are highly suitable for autologous cell-based therapies and do not face issues associated with other stem cells. However, their clinical use in humans and animals is limited due to a lack of preclinical studies on autologous transplantation and because no well-established methods currently exist to cultivate these cells. Here we evaluated the feasibility of collecting, purifying and amplifying OE-MSCs from different mammalian genera with the goal of promoting their interest in veterinary regenerative medicine. Biopsies of olfactory mucosa from eight mammalian genera (mouse, rat, rabbit, sheep, dog, horse, gray mouse lemur and macaque) were collected, using techniques derived from those previously used in humans and rats. The possibility of amplifying these cells and their stemness features and differentiation capability were then evaluated. RESULTS: Biopsies were successfully performed on olfactory mucosa without requiring the sacrifice of the donor animal, except mice. Cell populations were rapidly generated from olfactory mucosa explants. These cells displayed similar key features of their human counterparts: a fibroblastic morphology, a robust expression of nestin, an ability to form spheres and similar expression of surface markers (CD44, CD73). Moreover, most of them also exhibited high proliferation rates and clonogenicity with genus-specific properties. Finally, OE-MSCs also showed the ability to differentiate into mesodermal lineages. CONCLUSIONS: This article describes for the first time how millions of OE-MSCs can be quickly and easily obtained from different mammalian genera through protocols that are well-suited for autologous transplantations. Moreover, their multipotency makes them relevant to evaluate therapeutic application in a wide variety of tissue injury models. This study paves the way for the development of new fundamental and clinical studies based on OE-MSCs transplantation and suggests their interest in veterinary medicine.
Assuntos
Células-Tronco Adultas/citologia , Técnicas Citológicas/métodos , Mucosa Olfatória/citologia , Células-Tronco Adultas/fisiologia , Animais , Biópsia/métodos , Biópsia/veterinária , Técnicas de Cultura de Células , Diferenciação Celular , Mamíferos , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/fisiologia , Nestina/metabolismoRESUMO
Roles of vitamin D on the immune and nervous systems are increasingly recognized. Two previous studies demonstrated that ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) induced functional recovery and increased myelination in a rat model of peroneal nerve transection. The current report assessed whether cholecalciferol was efficient in repairing transected rabbit facial nerves. Animals were randomized into two groups of rabbits with an unilateral facial nerve surgery: the vitamin D group included animals receiving a weekly oral bolus of vitamin D3 (200 IU/kg/day), from day 1 post-surgery; the control group included animals receiving a weekly oral bolus of vehicle (triglycerides). Contralateral unsectioned facial nerves from all experimental animals were used as controls for the histological study. The facial functional index was measured every week while the inner diameter of myelin sheath and the G ratio were quantified at the end of the 3 month experiment. The current report indicates that cholecalciferol significantly increases functional recovery and myelination, after 12 weeks of treatment. To the best of our knowledge, this is the first study investigating the therapeutic benefit of vitamin D supplementation in an animal model of facial paralysis. It paves further the way for clinical trials based on the administration of this steroid in individuals with injured facial nerves.
Assuntos
Colecalciferol/farmacologia , Suplementos Nutricionais , Traumatismos do Nervo Facial/tratamento farmacológico , Fibras Nervosas Mielinizadas/efeitos dos fármacos , Recuperação de Função Fisiológica/fisiologia , Animais , Modelos Animais de Doenças , Traumatismos do Nervo Facial/fisiopatologia , Masculino , Coelhos , Vitaminas/farmacologiaRESUMO
Although tissue plasminogen activator (tPA) is known to promote neuronal remodeling in the CNS, no mechanism of how this plastic function takes place has been reported so far. We provide here in vitro and in vivo demonstrations that this serine protease neutralizes inhibitory chondroitin sulfate proteoglycans (CSPGs) by promoting their degradation via the direct activation of endogenous type 4 disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS-4). Accordingly, in a model of compression-induced spinal cord injury (SCI) in rats, we found that administration of either tPA or its downstream effector ADAMTS-4 restores the tPA-dependent activity lost after the SCI and thereby, reduces content of CSPGs in the spinal cord, a cascade of events leading to an improved axonal regeneration/sprouting and eventually long term functional recovery. This is the first study to reveal a tPA-ADAMTS-4 axis and its function in the CNS. It also raises the prospect of exploiting such cooperation as a therapeutic tool for enhancing recovery after acute CNS injuries.
Assuntos
Proteínas ADAM/metabolismo , Proteoglicanas de Sulfatos de Condroitina/metabolismo , Plasticidade Neuronal/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Pró-Colágeno N-Endopeptidase/metabolismo , Traumatismos da Medula Espinal/tratamento farmacológico , Ativador de Plasminogênio Tecidual/farmacologia , Proteína ADAMTS4 , Animais , Axônios/efeitos dos fármacos , Axônios/fisiologia , Células Cultivadas , Feminino , Neuritos/efeitos dos fármacos , Neuritos/fisiologia , Neurocam , Neuropeptídeos/farmacologia , Inibidor 1 de Ativador de Plasminogênio/farmacologia , Ratos , Ratos Wistar , Recuperação de Função Fisiológica , Inibidores de Serina Proteinase/farmacologia , Serpinas/farmacologia , Medula Espinal/efeitos dos fármacos , Medula Espinal/fisiopatologia , Compressão da Medula Espinal/tratamento farmacológico , Compressão da Medula Espinal/fisiopatologia , Traumatismos da Medula Espinal/fisiopatologia , Ativador de Plasminogênio Tecidual/antagonistas & inibidores , NeuroserpinaRESUMO
The 5XFAD mice are an early-onset transgenic model of Alzheimer's disease (AD) in which amyloid plaques are first observed between two and four months of age in the cortical layer five and in the subiculum of the hippocampal formation. Although cognitive alterations have been described in these mice, there are no studies that focused on the onset of hippocampus-dependent memory deficits, which are a hallmark of the prodromal stage of AD. To identify when the first learning and memory impairments appear, 5XFAD mice of two, four, and six months of age were compared with their respective wild-type littermates using the olfactory tubing maze, which is a very sensitive hippocampal-dependent task. Deficits in learning and memory started at four months with a substantial increase at six months of age while no olfactory impairments were observed. The volumetric study using magnetic resonance imaging of the whole brain and specific areas (olfactory bulb, striatum, and hippocampus) did not reveal neuro-anatomical difference. Slight memory deficits appeared at 4 months of age in correlation with an increased astrogliosis and amyloid plaque formation. This early impairment in learning and memory related to the hippocampal dysfunction is particularly suited to assess preclinical therapeutic strategies aiming to delay or suppress the onset of AD.
Assuntos
Doença de Alzheimer/psicologia , Hipocampo/fisiopatologia , Deficiências da Aprendizagem/etiologia , Transtornos da Memória/etiologia , Idade de Início , Doença de Alzheimer/fisiopatologia , Precursor de Proteína beta-Amiloide/genética , Animais , Astrócitos/patologia , Corpo Estriado/patologia , Gliose/etiologia , Gliose/patologia , Hipocampo/patologia , Deficiências da Aprendizagem/patologia , Deficiências da Aprendizagem/fisiopatologia , Imageamento por Ressonância Magnética , Masculino , Aprendizagem em Labirinto , Transtornos da Memória/patologia , Transtornos da Memória/fisiopatologia , Camundongos , Camundongos Transgênicos , Bulbo Olfatório/patologia , Tamanho do Órgão , Placa Amiloide/etiologia , Placa Amiloide/patologia , Mutação Puntual , Presenilina-1/genética , Olfato/fisiologiaRESUMO
BACKGROUND: Currently, autologous nerve implantation to bridge a long nerve gap presents the greatest regenerative performance in spite of substantial drawbacks. In this study, we evaluate the effect of two different collagen conduits bridging a peroneal nerve gap. METHODS: Rats were divided into four groups: (1) the gold standard group, in which a 10-mm-long nerve segment was cut, reversed, and reimplanted between the nerve stumps; (2) the CG-I/III group, in which a type I/III collagen conduit bridged the gap; (3) the CG-I, in which a type I collagen conduit was grafted; and (4) the sham group, in which a surgery was performed without injuring the nerve. Peroneal Functional Index and kinematics analysis of locomotion were performed weekly during the 12 weeks post-surgery. At the end of the protocol, additional electrophysiological tests, muscular weight measurements, axon counting, and g-ratio analysis were carried out. RESULTS: Functional loss followed by incomplete recovery was observed in animals grafted with collagen conduits. At 12 weeks post-surgery, the ventilatory rate of the CG-I group in response to exercise was similar to the sham group, contrary to the CG-I/III group. After KCl injections, an increase in metabosensitive afferent-fiber activity was recorded, but the response stayed incomplete for the collagen groups compared to the sham group. Furthermore, the CG-I group presented a higher number of axons and seemed to induce a greater axonal maturity compared to the CG-I/III group. CONCLUSIONS: Our results suggest that the grafting of a type I collagen conduit may present slight better prospects than a type I/III collagen conduit.
Assuntos
Axônios/patologia , Colágeno Tipo III , Colágeno Tipo I , Regeneração Nervosa , Nervo Fibular/cirurgia , Implantação de Prótese/métodos , Recuperação de Função Fisiológica , Animais , Masculino , Atrofia Muscular , Bainha de Mielina/metabolismo , Bainha de Mielina/patologia , Nervo Fibular/lesões , Nervo Fibular/transplante , RatosRESUMO
Sulfur is an important element that is incorporated into many biomolecules in humans. The incorporation and transfer of sulfur into biomolecules is, however, facilitated by a series of different sulfurtransferases. Among these sulfurtransferases is the human mercaptopyruvate sulfurtransferase (MPST) also designated as tRNA thiouridine modification protein (TUM1). The role of the human TUM1 protein has been suggested in a wide range of physiological processes in the cell among which are but not limited to involvement in Molybdenum cofactor (Moco) biosynthesis, cytosolic tRNA thiolation and generation of H2S as signaling molecule both in mitochondria and the cytosol. Previous interaction studies showed that TUM1 interacts with the L-cysteine desulfurase NFS1 and the Molybdenum cofactor biosynthesis protein 3 (MOCS3). Here, we show the roles of TUM1 in human cells using CRISPR/Cas9 genetically modified Human Embryonic Kidney cells. Here, we show that TUM1 is involved in the sulfur transfer for Molybdenum cofactor synthesis and tRNA thiomodification by spectrophotometric measurement of the activity of sulfite oxidase and liquid chromatography quantification of the level of sulfur-modified tRNA. Further, we show that TUM1 has a role in hydrogen sulfide production and cellular bioenergetics.
Assuntos
Cofatores de Molibdênio , Sulfurtransferases , Humanos , Citosol/metabolismo , Sulfurtransferases/metabolismo , Metabolismo Energético , Enxofre/metabolismo , RNA de Transferência/metabolismo , Rim/metabolismo , Liases de Carbono-Enxofre/metabolismoRESUMO
During peripheral nerve injury, Schwann cells (SCs) adopt a migratory phenotype and remodel the extracellular matrix and provide a supportive activity for neuron regeneration. SCs synthesize neurotrophic factors and cytokines that are crucial for the repair of the injured nerve. The receptor for advanced glycation end products (RAGE) and its ligand S100B, which are secreted by SCs, are required for the repair of the injured peripheral nerve in vivo. However, the precise intracellular pathways involved have not been completely elucidated. Here, we show that RAGE-induced S100B secretion involves the recruitment of S100B in lipid rafts and caveolae. Moreover, we demonstrate for the first time that RAGE induces the expression of thioredoxin interacting protein (TXNIP) in SCs and the injured sciatic nerve in vivo. TXNIP is involved in the activation of p38 MAPK, CREB and NFκB in SCs. TXNIP silencing partially inhibits RAGE-induced SC migration and completely abolishes RAGE-induced fibronectin and IL-1ß expression. Our results support a model in which TXNIP mediates in part RAGE-induced SC migration and is required for the expression of provisional ECM and pro-inflammatory IL-1ß. We provide new insight on the role of the SC RAGE-TXNIP axis in the repair of injured peripheral nerves.
Assuntos
Proteínas de Transporte/metabolismo , Movimento Celular , Fibronectinas/metabolismo , Interleucina-1beta/metabolismo , Fatores de Crescimento Neural/metabolismo , Receptores Imunológicos/metabolismo , Proteínas S100/metabolismo , Células de Schwann/citologia , Animais , Proteínas de Ciclo Celular , Ativação Enzimática , Masculino , Microdomínios da Membrana/metabolismo , Ratos , Ratos Sprague-Dawley , Receptor para Produtos Finais de Glicação Avançada , Subunidade beta da Proteína Ligante de Cálcio S100 , Células de Schwann/enzimologia , Nervo Isquiático/metabolismo , Nervo Isquiático/patologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismoRESUMO
Mounting evidence correlate vitamin D3 (cholecalciferol) supplementation or higher serum levels of vitamin D (25(OH)D) with a lower risk of developing multiple sclerosis (MS), reduced relapse rate, slower progression or fewer new brain lesions. We present here the case of a woman who was diagnosed with MS in 1990. From 1980 to 2000, her ability to walk decreased from ~20 to 1 km per day. Since January 2001, a vitamin D3 supplement was ingested daily. The starting dose was 20 mcg (800 IU)/day and escalated to 100 mcg (4000 IU)/day in September 2004 and then to 150 mcg (6000 IU)/day in December 2005. Vitamin D3 intake reduced muscular pain and improved ambulation from 1 (February 2000) to 14 km/day (February 2008). Vitamin D intake over 10 years caused no adverse effects: no hypercalcaemia, nephrolithiasis or hypercalciuria were observed. Bowel problems in MS may need to be addressed as they can cause malabsorption including calcium, which may increase serum PTH and 1,25(OH)2D levels, as well as bone loss. We suggest that periodic assessment of vitamin D3, calcium and magnesium intake, bowel problems and the measurement of serum 25(OH)D, PTH, Ca levels, UCa/Cr and bone health become part of the integral management of persons with MS.
Assuntos
Colecalciferol/administração & dosagem , Densidade Óssea , Conservadores da Densidade Óssea/administração & dosagem , Suplementos Nutricionais , Feminino , Humanos , Estudos Longitudinais , Esclerose Múltipla/tratamento farmacológico , Manejo da Dor , Hormônio Paratireóideo/sangue , Vitamina D/sangue , CaminhadaRESUMO
In a previous study, we demonstrated that mouse adult F(1) offspring, exposed to a vitamin D deficiency during pregnancy, developed a less severe and delayed Experimental Autoimmune Encephalomyelitis (EAE), when compared with control offspring. We then wondered whether a similar response was observed in the subsequent generation. To answer this question, we assessed F(2) females whose F(1) parents (males or females) were vitamin D-deprived when developing in the uterus of F(0) females. Unexpectedly, we observed that the vitamin D deficiency affecting the F(0) pregnant mice induced a precocious and more severe EAE in the F(2) generation. This paradoxical finding led us to assess its implications for the epidemiology of Multiple Sclerosis (MS) in humans. Using the REFGENSEP database for MS trios (the patient and his/her parents), we collected the parents' dates of birth and assessed a potential season of birth effect that could potentially be indicative of the vitamin D status of the pregnant grandmothers. A trend for a reduced number of births in the Fall for the parents of MS patients was observed but statistical significance was not reached. Further well powered studies are warranted to validate the latter finding.
Assuntos
Encefalomielite Autoimune Experimental/etiologia , Esclerose Múltipla/etiologia , Complicações na Gravidez/diagnóstico , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/diagnóstico , Animais , Encefalomielite Autoimune Experimental/diagnóstico , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Esclerose Múltipla/diagnóstico , Parto , Linhagem , Gravidez , Estações do AnoRESUMO
Background: Olfactory ecto-mesenchymal stem cells (OE-MSC) are mesenchymal stem cells derived from the lamina propria of the nasal mucosa. They display neurogenic and immunomodulatory properties and were shown to induce recovery in animal models of spinal cord trauma, hearing loss, Parkinsons's disease, amnesia, and peripheral nerve injury. As a step toward clinical practice, we sought to (i) devise a culture protocol that meets the requirements set by human health agencies and (ii) assess the efficacy of stem cells on neuron differentiation. Methods: Nasal olfactory mucosa biopsies from three donors were used to design and validate the good manufacturing process for purifying stem cells. All processes and procedures were performed by expert staff from the cell therapy laboratory of the public hospital of Marseille (AP-HM), according to aseptic handling manipulations. Premises, materials and air were kept clean at all times to avoid cross-contamination, accidents, or even fatalities. Purified stem cells were cultivated for 24 or 48 h and conditioned media were collected before being added to the culture medium of the neuroblastoma cell line Neuro2a. Results: Compared to the explant culture-based protocol, enzymatic digestion provides higher cell numbers more rapidly and is less prone to contamination. The use of platelet lysate in place of fetal calf serum is effective in promoting higher cell proliferation (the percentage of CFU-F progenitors is 15.5%), with the optimal percentage of platelet lysate being 10%. Cultured OE-MSCs do not show chromosomal rearrangement and, as expected, express the usual phenotypic markers of mesenchymal stem cells. When incorporated in standard culture medium, the conditioned medium of purified OE-MSCs promotes cell differentiation of Neuro2a neuroblastoma cells. Conclusion: We developed a safer and more efficient manufacturing process for clinical grade olfactory stem cells. With this protocol, human OE-MSCs will soon be used in a Phase I clinical based on their autologous transplantation in digital nerves with a neglected injury. However, further studies are required to unveil the underlying mechanisms of action.
RESUMO
Olfactory ensheathing cells (OECs) are unique glia found only in the olfactory system. They retain exceptional plasticity and support olfactory neurogenesis and retargeting across the PNS:CNS boundary in the olfactory system. OECs have been shown to improve functional outcome when transplanted into rodents with spinal cord injury. The growth-promoting properties of implanted OECs encompass their ability to migrate through the scar tissue and render it more permissive for axonal outgrowth, but the underlying molecular mechanisms remain poorly understood. OECs appear to regulate molecules of the extracellular matrix (ECM) that inhibit axonal growth. Among the proteins that have the potential to promote cell migration, axonal regeneration and remodeling of the ECM are matrix metalloproteinases (MMPs), a family of endopeptidases that cleave matrix, soluble, and membrane-bound proteins and that are regulated by their endogenous inhibitors, the tissue inhibitors of MMPs (TIMPs). Little is known about MMP/TIMP trafficking, secretion, and role in OECs. Using a combination of cell biology, biochemistry, pharmacology, and imaging techniques, we show that MMP-2 and MMP-9 are expressed and proteolytically active in the olfactory epithelium and in particular in the OECs of the lamina propria. These proteinases and regulatory proteins such as MT1-MMP and TIMP-2 are expressed in cultured OECs. MMPs exhibit nuclear localization and vesicular trafficking and secretion, with distribution along microtubules and microfilaments and co-localization with the molecular motor protein kinesin. Finally, we show that MMPs are involved in migration of OECs in vitro on different ECM substrates.
Assuntos
Movimento Celular/fisiologia , Metaloproteinase 2 da Matriz/metabolismo , Neuroglia/metabolismo , Mucosa Olfatória/metabolismo , Animais , Western Blotting , Células Cultivadas , Feminino , Imunofluorescência , Imuno-Histoquímica , Metaloproteinase 9 da Matriz/metabolismo , Mucosa Olfatória/citologia , Transporte Proteico/fisiologia , Ratos , Ratos Endogâmicos Lew , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Inibidor Tecidual de Metaloproteinase-2/metabolismoRESUMO
Three experiments are reported, which investigated the auditory velocity thresholds beyond which listeners are no longer able to perceptually resolve a smooth circular trajectory. These thresholds were measured for band-limited noises, white noise, and harmonic sounds (HS), and in different acoustical environments. Experiments 1 and 2 were conducted in an acoustically dry laboratory. Observed thresholds varied as a function of stimulus type and spectral content. Thresholds for band-limited noises were unaffected by center frequency and equal to that of white noise. For HS, however, thresholds decreased as the fundamental frequency of the stimulus increased. The third experiment was a replication of the second in a reverberant concert hall, which produced qualitatively similar results except that thresholds were significantly higher than in the acoustically dry laboratory.
Assuntos
Vias Auditivas/fisiologia , Percepção Auditiva , Localização de Som , Estimulação Acústica , Adulto , Audiometria , Limiar Auditivo , Feminino , Humanos , Masculino , Movimento (Física) , Ruído/efeitos adversos , Mascaramento Perceptivo , Rotação , Vibração , Adulto JovemRESUMO
Vitamin D is a steroid hormone implicated in the regulation of neuronal integrity and many brain functions. Its influence, as a nutrient and a hormone, on the physiopathology of the most common neurodegenerative diseases is continuously emphasized by new studies. This review addresses what is currently known about the action of vitamin D on the nervous system and neurodegenerative diseases such as Multiple Sclerosis, Alzheimer's disease, Parkinson's disease and Amyotrophic Lateral Sclerosis. Further vitamin D research is necessary to understand how the action of this "neuroactive" steroid can help to optimize the prevention and treatment of several neurological diseases.
Assuntos
Doença de Alzheimer , Esclerose Múltipla , Humanos , Vitamina D , VitaminasRESUMO
In line with experiments showing that implanted hydrogels are promising tools, we designed and injected, after a C2 spinal cord hemisection, a thermoresponsive and thermoreversible physically cross-linked poly(N-isopropylacrylamide)-poly(ethylene glycol) copolymer in order to reduce functional deficits and provide a favorable environment to axotomized axons. Nasal olfactory ecto-mesenchymal stem cells were cultured on the hydrogel in order to verify its biocompatibility. Then, inflammatory reaction (Interleukin-1ß and 6, Tumor Necrosis Factor-α) was examined 15 days post-hydrogel injection. Functional recovery (postural and locomotor activities, muscle strength and tactile sensitivity) was assessed once a week, during 12 weeks. Finally, at 12 weeks post-injection, spinal reflexivity and ventilatory adjustments were measured, and the presence of glial cells and regenerated axons were determined in the injured area. Our results indicate that cells survived and proliferated on the hydrogel which, itself, did not induce an enhanced inflammation. Furthermore, we observed significant motor and sensitive improvements in hydrogel-injected animals. Hydrogel also induced H-reflex recovery close to control animals but no improved ventilatory adjustment to electrically-evoked isometric contractions. Finally, regrowing axons were visualized within the hydrogel with no glial cells colonization. Our results emphasize the effectiveness of our copolymer and its high therapeutic potential to repair the spinal cord after injury.
Assuntos
Hidrogéis/química , Hidrogéis/farmacologia , Traumatismos da Medula Espinal/tratamento farmacológico , Resinas Acrílicas/química , Animais , Axônios/efeitos dos fármacos , Proliferação de Células , Reagentes de Ligações Cruzadas/química , Eletrofisiologia , Feminino , Hidrogéis/administração & dosagem , Injeções Espinhais , Teste de Materiais , Células-Tronco Mesenquimais/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Mielite/tratamento farmacológico , Mielite/patologia , Polietilenoglicóis/química , Ratos Sprague-Dawley , Reflexo/efeitos dos fármacos , Medula Espinal/patologia , Traumatismos da Medula Espinal/complicações , Traumatismos da Medula Espinal/fisiopatologiaRESUMO
BACKGROUND: Posttraumatic facial paralysis is a disabling condition. Current surgical management by faciofacial nerve suture provides limited recovery. To improve the outcome, the authors evaluated an add-on strategy based on a syngeneic transplantation of nasal olfactory stem cells in a rat model of facial nerve injury. The main readouts of the study were the recording of whisking function and buccal synkinesis. METHODS: Sixty rats were allocated to three groups. Animals with a 2-mm facial nerve loss were repaired with a femoral vein, filled or not with olfactory stem cells. These two groups were compared to similarly injured rats but with a faciofacial nerve suture. Olfactory stem cells were purified from rat olfactory mucosa. Three months after surgery, facial motor performance was evaluated using video-based motion analysis and electromyography. Synkinesis was assessed by electromyography, using measure of buccal involuntary movements during blink reflex, and double retrograde labeling of regenerating motoneurons. RESULTS: The authors' study reveals that olfactory stem cell transplantation induces functional recovery in comparison to nontransplanted and faciofacial nerve suture groups. They significantly increase (1) maximal amplitude of vibrissae protraction and retraction cycles and (2) angular velocity during protraction of vibrissae. They also reduce buccal synkinesis, according to the two techniques used. However, olfactory stem cell transplantation did not improve axonal regrowth of the facial nerve, 3 months after surgery. CONCLUSIONS: The authors show here that the adjuvant strategy of syngeneic transplantation of olfactory stem cells improves functional recovery. These promising results open the way for a phase I clinical trial based on the autologous engraftment of olfactory stem cells in patients with a facial nerve paralysis.
Assuntos
Traumatismos do Nervo Facial/cirurgia , Paralisia Facial/cirurgia , Transplante de Células-Tronco/métodos , Sincinesia/cirurgia , Enxerto Vascular/métodos , Animais , Técnicas de Observação do Comportamento , Modelos Animais de Doenças , Eletromiografia , Nervo Facial/fisiopatologia , Nervo Facial/cirurgia , Traumatismos do Nervo Facial/complicações , Traumatismos do Nervo Facial/fisiopatologia , Paralisia Facial/diagnóstico , Paralisia Facial/etiologia , Paralisia Facial/fisiopatologia , Feminino , Veia Femoral/transplante , Humanos , Regeneração Nervosa/fisiologia , Mucosa Olfatória/citologia , Ratos , Recuperação de Função Fisiológica , Sincinesia/diagnóstico , Sincinesia/etiologia , Sincinesia/fisiopatologia , Transplante Isogênico/métodos , Vibrissas/inervação , Vibrissas/fisiologia , Gravação em VídeoRESUMO
Parkinson's disease is a complex disorder characterized by degeneration of dopaminergic neurons in the substantia nigra in the brain. Stem cell transplantation is aimed at replacing dopaminergic neurons because the most successful drug therapies affect these neurons and their synaptic targets. We show here that neural progenitors can be grown from the olfactory organ of humans, including those with Parkinson's disease. These neural progenitors proliferated and generated dopaminergic cells in vitro. They also generated dopaminergic cells when transplanted into the brain and reduced the behavioral asymmetry induced by ablation of the dopaminergic neurons in the rat model of Parkinson's disease. Our results indicate that Parkinson's patients could provide their own source of neuronal progenitors for cell transplantation therapies and for direct investigation of the biology and treatments of Parkinson's disease. Disclosure of potential conflicts of interest is found at the end of this article.